Endothelial cells Sample Clauses

Endothelial cells. Common to all vessels of the vasculature is the endothelium, which is a single layered sheet of squamous, polarised cells that are primarily responsible for all signalling and transportation from blood to tissue and vice versa (Cines et al. 1998). Different types of endothelial cells have been isolated and cultured to understand the biology and pathobiology of the vasculature and the angiogenic response (Xxxxxx et al. 2010). The cells most widely used in in vitro studies are isolated from human umbilical vein, HUVEC, which show a characteristic cobblestone shape when cultured. HUVEC are the most extensively studied endothelial cell type, primarily because they are relatively easy to isolate and culture (Xxxxxx et al. 2010). In vivo, angiogenesis is mediated by the microvasculature and the angiogenic response of human microvascular endothelial cells (HMVEC), which has been suggested to be stronger than that of HUVEC because of differing expression of matrix metalloproteases (Xxxxxxx & Xxxxxx 1997). However, HMVEC are generally more fastidious in their culture requirements than HUVEC making long-term culture more challenging (Xxxxxx et al. 2010). Functional studies of endothelial cells have been carried out in culture, as endothelial cells cultured in the presence of an ECM organise themselves into tube-like structures (Xxxxxx et al. 2010). This response is seen as a mimic of natural endothelial behaviour during angiogenesis, and as such has been used as a simple in vitro angiogenesis assay (Xxxxxx et al. 2010). As expected for endothelial cells, low passage HUVEC form tube-like structures when cultured on top of gels formed by ECM proteins such as collagen-1 or Matrigel (Xxxxx et al. 2002). However, such studies have not been reported for microvascular endothelial cells, although these cells are directly involved in angiogenesis (Xxxxxx et al. 2010). While endothelial cells in vivo are normally quiescent, cultured endothelial cells are maintained in an artificially activated state characterised by extensive proliferation (Xxxxxxx & El Xxxxxx 2004). Airway endothelial cells are a source of chemokines that may contribute to the recruitment and the activation of basophils, eosinophils and lymphocytes into the airways (Xxxxxxx & El Xxxxxx 2004).
AutoNDA by SimpleDocs

Related to Endothelial cells

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccination The parties agree that influenza vaccinations may be beneficial for patients and employees. Upon a recommendation pertaining to a facility or a specifically designated area(s) thereof from the Medical Officer of Health or in compliance with applicable provincial legislation, the following rules will apply:

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Rhytidectomy Scar revision, regardless of symptoms. • Sclerotherapy for spider veins. • Skin tag removal. • Subcutaneous injection of filling material. • Suction assisted Lipectomy. • Tattooing or tattoo removal except tattooing of the nipple/areola related to a mastectomy. • Treatment of vitiligo. • Standby services of an assistant surgeon or anesthesiologist. • Orthodontic services related to orthognathic surgery. • Cosmetic procedures when performed primarily: o to refine or reshape body structures or dental structures that are not functionally impaired; o to improve appearance or self-esteem; or o for other psychological, psychiatric or emotional reasons. • Drugs, biological products, hospital charges, pathology, radiology fees and charges for surgeons, assistant surgeons, attending physicians and any other incidental services, which are related to cosmetic surgery.

  • Geometric visibility The visibility of the illuminating surface, including its visibility in areas which do not appear to be illuminated in the direction of observation considered, shall be ensured within a divergent space defined by generating lines based on the perimeter of the illuminating surface and forming an angle of not less than 5° with the axis of reference of the headlamp. The origin of the angles of geometric visibility is the perimeter of the projection of the illuminating surface on a transverse plane tangent to the foremost part of the lens of the headlamp.

  • Prosthetics Crowns and Bridges (Plan B) paying for 60% of the approved Schedule of Fees.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Prosthodontics We Cover prosthodontic services as follows: • Removable complete or partial dentures, for Members 15 years of age and above, including six (6) months follow-up care; • Additional services including insertion of identification slips, repairs, relines and rebases and treatment of cleft palate; and • Interim prosthesis for Members five (5) to 15 years of age. We do not Cover implants or implant related services. Fixed bridges are not Covered unless they are required: • For replacement of a single upper anterior (central/lateral incisor or cuspid) in a patient with an otherwise full complement of natural, functional and/or restored teeth; • For cleft palate stabilization; or • Due to the presence of any neurologic or physiologic condition that would preclude the placement of a removable prosthesis, as demonstrated by medical documentation.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Cultivation Lessee shall cultivate the demised premises according to generally accepted agricultural practices practiced in the County of , State of .

Time is Money Join Law Insider Premium to draft better contracts faster.